Back to all news
AI Model Predicts Colorectal Cancer Survival by Integrating Clinical and Molecular Data
A research team developed a machine learning model that predicts colorectal cancer survival using combined clinical and molecular features, achieving high accuracy.
Key Details
- 1Study analyzed data from over 500 colorectal cancer patients using clinical (age, stage, chemotherapy) and molecular (gene/microRNA) features.
- 2Adaptive boosting ML model achieved 89.58% accuracy for survival prediction.
- 3Key predictive features included pathological stage, E2F8 gene expression, WDR77, and hsa-miR-495-3p microRNA.
- 4Combining clinical and biological data outperformed models using either data type alone.
- 5Study used publicly available data from the TCGA database; patient lifestyle factors were not included but seen as important for future work.
Why It Matters
The integration of clinical and molecular data using machine learning could enhance personalized risk stratification and treatment planning in colorectal cancer, an area of substantial clinical need. Such research advances the potential for AI-driven precision medicine in oncology and radiology.
Source
EurekAlert
Related News
•EurekAlert
Stanford's SleepFM AI Predicts 130 Disease Risks from Polysomnography
Stanford researchers have developed SleepFM, an AI model that predicts over 100 diseases using one night of sleep study data.
•EurekAlert
MIT and Microsoft Use AI to Develop Molecular Sensors for Early Cancer Detection
MIT and Microsoft researchers created an AI model to design peptide-based sensors for ultra-early cancer detection by detecting cancer-specific enzymes.
•EurekAlert
AI-Enhanced ECGs Enable Early COPD Detection Across Large Cohorts
Mount Sinai researchers show that deep learning applied to ECGs can detect COPD early and accurately across diverse populations.